Georgia Erbez
CIK 1557930 · See Remarks · last filed 2026-02-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$160.3K
Companies
8
Total Filings
28
Lifetime Open-Market Net
$311.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CDXS | See Remarks | 66,810 | $2.40 | $160.3K | -$20.6K | 5 | 2026-02-25 |
| CHRS | Director | — | $1.40 | — | $0 | 3 | 2025-06-13 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | — | $54.99 | — | $0 | 2 | 2022-07-01 |
| Harpoon Therapeutics, Inc. (HARP) Delisted | Chief Financial Officer | 91,507 | $23.01 | $2.11M | $279.0K | 10 | 2022-02-01 |
| ARTELO BIOSCIENCES, INC. (ARTLW) Delisted | Director | — | $0.01 | — | $0 | 1 | 2019-08-30 |
| Zosano Pharma Corp (ZSAN) Delisted | CFO and Chief Business Officer | 115,750 | $0.56 | $64.5K | $152.8K | 3 | 2017-05-25 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | Exec VP & CFO | — | — | — | $0 | 1 | 2015-11-12 |
| Raptor Pharmaceutical Corp (RPTP) Delisted | Chief Financial Officer | 2,500 | — | — | -$99.3K | 3 | 2014-02-11 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-11-15 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-09-22 | Harpoon Therapeutics, Inc. (HARP) Delisted | Buy (P) | +10,300 | $83.4K | EDGAR |
| 2021-06-04 | Sierra Oncology, Inc. (SRRA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-18 | Harpoon Therapeutics, Inc. (HARP) Delisted | Exer (M) | +25,000 | $53.0K | EDGAR |
| 2021-01-29 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-20 | Harpoon Therapeutics, Inc. (HARP) Delisted | Buy (P) | +7,098 | $81.3K | EDGAR |
| 2020-08-04 | Harpoon Therapeutics, Inc. (HARP) Delisted | Buy (P) | +1,817 | $19.8K | EDGAR |
| 2020-02-04 | Harpoon Therapeutics, Inc. (HARP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-23 | Harpoon Therapeutics, Inc. (HARP) Delisted | Buy (P) | +6,700 | $94.4K | EDGAR |
| 2019-12-06 | Harpoon Therapeutics, Inc. (HARP) Delisted | Exer (M) | +47,292 | $100.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.